These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 14529355)

  • 21. Human papillomavirus: disease and laboratory diagnosis.
    Swygart C
    Br J Biomed Sci; 1997 Dec; 54(4):299-303. PubMed ID: 9624741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in antiviral therapy.
    Wu JJ; Pang KR; Huang DB; Tyring SK
    Dermatol Clin; 2005 Apr; 23(2):313-22. PubMed ID: 15837157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Why Human Papillomavirus Acute Infections Matter.
    Alizon S; Murall CL; Bravo IG
    Viruses; 2017 Oct; 9(10):. PubMed ID: 28994707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular targets for human papillomaviruses: prospects for antiviral therapy.
    Phelps WC; Barnes JA; Lobe DC
    Antivir Chem Chemother; 1998 Sep; 9(5):359-77. PubMed ID: 9875390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Papillomaviruses in human cancers.
    zur Hausen H
    Proc Assoc Am Physicians; 1999; 111(6):581-7. PubMed ID: 10591087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insights into the mechanism of action of cidofovir and other acyclic nucleoside phosphonates against polyoma- and papillomaviruses and non-viral induced neoplasia.
    Andrei G; Topalis D; De Schutter T; Snoeck R
    Antiviral Res; 2015 Feb; 114():21-46. PubMed ID: 25446403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Large plantar wart caused by human papillomavirus-66 and resolution by topical cidofovir therapy.
    Davis MD; Gostout BS; McGovern RM; Persing DH; Schut RL; Pittelkow MR
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 2):340-3. PubMed ID: 10901717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phylogenetic analysis of the human papillomavirus type 2 (HPV-2), HPV-27, and HPV-57 group, which is associated with common warts.
    Chan SY; Chew SH; Egawa K; Grussendorf-Conen EI; Honda Y; Rübben A; Tan KC; Bernard HU
    Virology; 1997 Dec; 239(2):296-302. PubMed ID: 9434721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review of HPV-related diseases and cancers.
    Brianti P; De Flammineis E; Mercuri SR
    New Microbiol; 2017 Apr; 40(2):80-85. PubMed ID: 28368072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mastication of verruca vulgaris associated with esophageal papilloma: HPV-45 sequences detected in oral and cutaneous tissues.
    Ratoosh SL; Glombicki AP; Lockhart SG; Rady PL; Chin R; Arany I; Hughes TK; Tyring SK
    J Am Acad Dermatol; 1997 May; 36(5 Pt 2):853-7. PubMed ID: 9146567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting Persistent Human Papillomavirus Infection.
    Shanmugasundaram S; You J
    Viruses; 2017 Aug; 9(8):. PubMed ID: 28820433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human papillomavirus: often harmless but in some cases carcinogenic.
    Prescrire Int; 2007 Jun; 16(89):115-9. PubMed ID: 17585425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomic characterization of a novel human papillomavirus (HPV-117) with a high viral load in a persisting wart.
    Köhler A; Gottschling M; Förster J; Röwert-Huber J; Stockfleth E; Nindl I
    Virology; 2010 Mar; 399(1):129-133. PubMed ID: 20096912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genitoanal human papillomavirus infection and associated neoplasias.
    Gross G
    Curr Probl Dermatol; 2014; 45():98-122. PubMed ID: 24643181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human papillomavirus: current status and issues of vaccination.
    Malik H; Khan FH; Ahsan H
    Arch Virol; 2014 Feb; 159(2):199-205. PubMed ID: 24022639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Virological and carcinogenic aspects of HPV].
    Prétet JL; Charlot JF; Mougin C
    Bull Acad Natl Med; 2007 Mar; 191(3):611-23; discussion 623. PubMed ID: 18072657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients.
    Shamanin V; zur Hausen H; Lavergne D; Proby CM; Leigh IM; Neumann C; Hamm H; Goos M; Haustein UF; Jung EG; Plewig G; Wolff H; de Villiers EM
    J Natl Cancer Inst; 1996 Jun; 88(12):802-11. PubMed ID: 8637046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human papillomavirus update with a particular focus on cervical disease.
    Garland SM
    Pathology; 2002 Jun; 34(3):213-24. PubMed ID: 12109780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Reservoir of Persistent Human Papillomavirus Infection; Strategies for Elimination Using Anti-Viral Therapies.
    Zheng K; Egawa N; Shiraz A; Katakuse M; Okamura M; Griffin HM; Doorbar J
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial).
    Murray ML; Meadows J; Doré CJ; Copas AJ; Haddow LJ; Lacey C; Jit M; Soldan K; Bennett K; Tetlow M; Nathan M; Gilson R
    BMC Med Res Methodol; 2018 Nov; 18(1):125. PubMed ID: 30400777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.